Drugs & medicalClass III

Baxter Healthcare Corporation recalls Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare…

Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.

Read the official notice →
Date
2023-08-30
Country
United States
Brand
Baxter Healthcare
Product
Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation,…
Classification
Class III
Units
Nationwide in the U.S.A.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Baxter Healthcare recalls

  1. 2023-10-04
  2. US
    Drugs & medicalClass II

    Baxter Healthcare Corporation recalls Baxter Epiphany Cardio Server E3 ECG Management System Servers with software versions: a) v6.1.x, b) v6.2.x, c) v7.0.x.

    Epiphany, now a Baxter Healthcare company, is issuing an Urgent Medical Device Correction for the Cardio Server E3 ECG Management System software listed below due to a report of the caliper tool becoming…

    FDA · DeviceBaxter Healthcare CorporationWorldwide distribution - US Nationwide distribution including in the states of…Official notice →
  3. 2023-09-20
  4. US
    Drugs & medicalClass II

    Baxter Healthcare Corporation recalls Welch Allyn Connex Spot Monitor

    Product is being recalled due to the improper placement of a copper tape on the back of the liquid-crystal display.

    FDA · DeviceBaxter Healthcare CorporationUS Nationwide distribution in the state of CA.Official notice →
  5. 2023-09-06
  6. US
    Drugs & medicalClass II

    Baxter Healthcare Corporation recalls Dianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose, 5000 mL AMBU-FLEX ll Container with yellow pull ring, Rx Only, Baxter…

    Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

    FDA · DrugBaxter Healthcare CorporationNationwide in the USAOfficial notice →
  7. 2023-07-26
  8. US
    Drugs & medicalClass II

    Baxter Healthcare Corporation recalls GEM FLOW COUPLER Monitor, PN 5156-00000-011

    An issue was identified where the LCD monitor display may not indicate the correct active channel. The issue occurs when the monitor is turned on using battery power, and channel B was selected as the last active…

    FDA · DeviceBaxter Healthcare CorporationUSOfficial notice →
  9. 2023-07-19
  10. US
    Drugs & medicalClass II

    Baxter Healthcare Corporation recalls Allen Advance Chest Support with Pad

    Potential for the device to crack where the Chest Base Prone support attaches to the carbon fiber operating room (OR) table rail.

    FDA · DeviceBaxter Healthcare CorporationWorldwide distribution - US Nationwide and the countries of Canada, Australia,…Official notice →
  11. US
    Drugs & medicalClass I

    Baxter Healthcare Corporation recalls The Spectrum IQ Infusion System with Dose IQ Safety Software, Product Code 3570009

    A medical device correction is being issued for SIGMA Spectrum Infusion System (V8 Platform) and Spectrum IQ Infusion System with Dose IQ Safety Software infusion pumps due to an increase in reported false upstream…

    FDA · DeviceBaxter Healthcare CorporationUS Nationwide distribution.Official notice →
All 123 Baxter Healthcare recalls →

Other drugs & medical recalls in the United States

  1. 2023-08-30
  2. US
    Drugs & medicalClass I

    Draeger Medical, Inc. recalls Carina Sub-Acute Care Ventilator

    Presence of polyether polyurethane (PE-PUR) and emission of 1,3-Dichloropropan-2-ol that exceed the acceptable uptake level during continuous use (>30 days) in pediatric patients.

    FDA · DeviceDraeger Medical, Inc.US Nationwide Distribution.Official notice →
  3. US
    Drugs & medicalClass II

    TMC Acquisitions LLC dba Tailor Made Compounding recalls Semaglutide/Cyanocobalamin 2mg/0.4mg/mL, 1mLvials, Tailor Made Compounding.

    Lack of Assurance of Sterility

    FDA · DrugTMC Acquisitions LLC dba Tailor Made CompoundingNationwide within the USAOfficial notice →
  4. US
    Drugs & medicalClass II

    Inmar Supply Chain Solutions, LLC recalls All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

    CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage…

    FDA · DrugInmar Supply Chain Solutions, LLCSeparate Distribution List (salvage buyers) provided by Inmar and will be…Official notice →
  5. US
    Drugs & medicalClass II

    Ecometics, Inc. recalls activator concentrate, Sodium Fluoride 0.96% in Activator Concentrate; 0.08% in diluted Activator Solution, Net 1 FL. OZ., Manufactured…

    CGMP Deviations: Products not manufactured under current good manufacturing practices.

    FDA · DrugEcometics, Inc.Nationwide in the USAOfficial notice →
  6. US
    Drugs & medicalClass III

    Glenmark Pharmaceuticals Inc., USA recalls Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by:…

    Subpotent: Out of Specification for Assay Test at the 3-month time point.

    FDA · DrugGlenmark Pharmaceuticals Inc., USAnationwide in the U.S.Official notice →
  7. US
    Drugs & medicalClass III

    Imprimis NJOF, LLC recalls Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B,…

    Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.

    FDA · DrugImprimis NJOF, LLCNationwide in the USOfficial notice →
See all drugs & medical recalls →